Related Experiment Video
Updated: May 9, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Epigenetically Regulating Non-coding RNAs in Colorectal Cancer: Promises and Potentials
Zahra Taheri1, Majid Zaki-Dizaji2
1Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Abstract:
Colorectal cancer (CRC) is a common malignancy with high mortality. Despite advancements in understanding its molecular causes and improved drug therapies, patient survival rates remain low. The main reasons for the high mortality rate are cancer metastasis and the emergence of drug-resistant cancer cell populations. While genetic changes are recognized as the main driver of CRC occurrence and progression, recent studies suggest that epigenetic regulation is a crucial marker in cancer, influencing the interplay between genetics and the environment. Research has shown the significant regulatory roles of non-coding RNAs (ncRNAs) in CRC development. This review explores epigenetically regulated ncRNAs and their functions, aiming to understand key regulatory mechanisms that impact CRC development. Additionally, it discusses the potential use of these ncRNAs in CRC diagnosis, prognosis, and targeted treatments.
Insights
Epigenetic regulation of non-coding RNAs (ncRNAs) plays a crucial role in colorectal cancer (CRC) development, influencing metastasis and drug resistance. Understanding these ncRNAs offers potential for novel CRC diagnostics and targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Colorectal cancer (CRC) presents a significant global health challenge with high mortality rates, often due to metastasis and drug resistance.
- While genetic alterations are primary drivers, epigenetic modifications are increasingly recognized as critical regulators in cancer development.
- Non-coding RNAs (ncRNAs) are key epigenetic regulators implicated in the progression of various cancers, including CRC.
Purpose of the Study:
- To review the role of epigenetically regulated ncRNAs in colorectal cancer development.
- To elucidate the key regulatory mechanisms involving ncRNAs in CRC.
- To explore the potential of ncRNAs as biomarkers for CRC diagnosis, prognosis, and therapeutic targets.
Main Methods:
- Literature review focusing on epigenetics and non-coding RNAs in colorectal cancer.
- Analysis of studies investigating the functional roles of ncRNAs in CRC progression.
- Synthesis of current research on ncRNA-mediated epigenetic regulation in CRC.
Main Results:
- Epigenetically regulated ncRNAs significantly influence CRC initiation, progression, metastasis, and drug resistance.
- Specific ncRNAs are dysregulated in CRC, impacting key cellular pathways.
- These ncRNAs demonstrate potential as sensitive and specific biomarkers for CRC.
Conclusions:
- Epigenetic regulation by ncRNAs is integral to colorectal cancer pathogenesis.
- Targeting specific ncRNAs offers a promising avenue for novel CRC therapeutic strategies.
- Further research into ncRNA epigenetics can enhance CRC patient outcomes through improved diagnostics and treatments.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
lncRNA - Long Non-coding RNAs
RNA Stability
MicroRNAs
Regulation of Expression at Multiple Steps
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

